查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1821604

2025年干细胞检测全球市场报告

Stem Cell Assay Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年干细胞检测市场规模将呈指数级增长，到2029年将达到63.5亿美元，年复合成长率（CAGR）为22.2%。预测期内的主要趋势包括3D细胞培养模型、高通量筛检、个人化医疗、CRISPR-Cas9和基因组编辑以及药物安全性和毒性测试。

未来五年22.2%的成长率预测比我们先前的预测略有下降，下降了0.2%。这一下降主要源自于美国与其他国家之间关税的影响。预计关税壁垒将阻碍美国，因为这将增加来自瑞典和英国的流式细胞技术套件和3D类器官检测平台的成本，从而延迟治疗方法检验并提高生物製药研发成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，关税壁垒的影响也将更加广泛。

慢性病盛行率的上升预计将推动未来干细胞检测市场的成长。慢性病是指持续时间超过三个月且可能随着时间的推移而恶化的疾病。干细胞具有治疗多种疾病的潜力，包括慢性病。干细胞促进新抗体和特化细胞的发育，有助于治疗癌症等慢性疾病。例如，根据英国世界癌症研究基金会国际部的数据，2022 年，英国有 50,700 例肺癌病例，发生率为每 10 万人 30.1 人。同年，英国有 16,855 名女性死于肺癌，死亡率为每 10 万人 17.4 人。此外，2024年3月，英国政府数据显示，截至2023财年，英格兰有超过1,862,500人（占总人口的3%）被全科医生诊断出患有心臟疾病（CHD）。因此，慢性病的增加正在推动干细胞检测市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球干细胞检测：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球干细胞检测市场：成长率分析
  • 全球干细胞检测市场表现：规模与成长，2019-2024
  • 全球干细胞检测市场预测：规模与成长，2024-2029年，2034年
  • 全球干细胞检测：总潜在市场（TAM）

第六章 市场细分

  • 全球干细胞检测市场：依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 细胞活力和毒性测定
  • 细胞凋亡检测
  • 细胞功能检测
  • 细胞识别分析
  • 分离纯化试验
  • 细胞分化试验
  • 其他类型
  • 全球干细胞检测市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 检测试剂套件
  • 全球干细胞检测市场：依应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 再生医学和治疗方法发展
  • 药物研发
  • 临床研究
  • 全球干细胞检测市场：按最终用户、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 政府研究机构
  • 私人研究机构
  • 产业研究
  • 全球干细胞检测市场：依细胞活力及毒性检测（按类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • MTT 检测
  • 刃天青测定
  • ATP测定
  • LDH释放试验
  • 全球干细胞检测市场：依细胞凋亡检测细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 胱天蛋白酶活性测定
  • 膜联蛋白V染色试验
  • TUNEL 检测
  • 细胞死亡检测试验
  • 全球干细胞检测市场：依细胞功能检测（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 增殖试验
  • 迁移和侵袭试验
  • 分化试验
  • 全球干细胞检测市场：依细胞辨识检测（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 基于流式细胞技术的检测
  • 表面标誌物表征
  • 免疫细胞化学检测
  • 全球干细胞检测市场：依分离纯化检测类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 磁激活细胞分选（MACS）
  • 萤光活化细胞分选术（FACS）
  • 密度梯度离心
  • 全球干细胞检测市场：依细胞分化检测类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 谱系特异性分化试验
  • 分化过程中的基因表现分析
  • 全球干细胞检测市场：按类型细分、按类型细分、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 3D培养试验
  • 高内涵筛检分析
  • 生物标记发现检测

第七章 区域和国家分析

  • 全球干细胞检测市场：区域表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 全球干细胞检测市场：依国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 干细胞检测市场：竞争格局
  • 干细胞检测市场：公司简介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • PerkinElmer Inc.
  • Agilent Technologies Inc.
  • Promega Corporation
  • Cell Biolabs Inc.
  • Miltenyi Biotec GmbH
  • STEMCELL Technologies Inc.
  • Bio-Techne Corporation
  • Charles River Laboratories International Inc.
  • Hemogenix Inc.
  • Lonza Group AG
  • Takara Bio Inc.
  • Creative Bioarray
  • AAT Bioquest Inc.
  • BPS Bioscience Inc.
  • Enzo Life Sciences Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年干细胞检测市场：提供新机会的国家
  • 2029年干细胞检测市场：细分领域将带来新机会
  • 2029年干细胞检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r22166u

Stem cells are cells possessing the unique ability to self-renew and differentiate into specialized cell types, serving as the foundational elements for all living organisms. Stem cell assays are specifically designed to explore the growth of human stem cells and examine their biological activities within a controlled environment.

The primary categories within the stem cell assays market include cell viability and toxicity assays, cell apoptosis assays, cell function assays, cell identification assays, isolation and purification assays, and cell differentiation assays, among others. Cell viability and toxicity assays are employed to evaluate the physical and physiological health of cells under various conditions, such as exposure to external stimuli, chemical agents, medicinal treatments, or other factors, aiding in the determination of optimal conditions for cell culture growth. Products associated with these assays include instruments and detection kits utilized in diverse applications like regenerative medicine, therapy development, drug discovery, and clinical research. End users span government research institutes, private research institutes, and industry research.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The stem cell assay market research report is one of a series of new reports from The Business Research Company that provides stem cell assay market statistics, including stem cell assay industry global market size, regional shares, competitors with an stem cell assay market share, detailed stem cell assay market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell assay industry. This stem cell assay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stem cell assay market size has grown exponentially in recent years. It will grow from $2.36 billion in 2024 to $2.84 billion in 2025 at a compound annual growth rate (CAGR) of 20.5%. The growth in the historic period can be attributed to biotechnology advancements, drug discovery and development, regenerative medicine research, disease modeling, public and private investment.

The stem cell assay market size is expected to see exponential growth in the next few years. It will grow to $6.35 billion in 2029 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to personalized medicine and cellTherapy, organoid and tissue engineering, ai and machine learning, emerging technologies, regulatory and ethical considerations.Major trends in the forecast period include 3D cell culture models, high-throughput screening, personalized medicine, crispr-cas9 and genome editing, drug safety and toxicity testing.

The forecast of 22.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S.by increasing the cost of flow cytometry kits and 3D organoid assay platforms sourced from Sweden and the UK, thereby slowing therapeutic validation and elevating biopharmaceutical R&D expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic diseases is anticipated to drive the growth of the stem cell assay market in the future. Chronic diseases are defined as ailments or illnesses that persist for three months or longer and may worsen over time. Stem cells possess the potential to treat various diseases, including chronic conditions. They facilitate the development of new antibodies and specialized cells that aid in curing chronic diseases such as cancer. For example, in 2022, data from The World Cancer Research Fund International, a UK-based organization, indicated that there were 50,700 lung cancer cases in the United Kingdom, corresponding to a rate of 30.1 per 100,000 people. That year, 16,855 women died from lung cancer in the UK, resulting in a mortality rate of 17.4 per 100,000. Furthermore, in March 2024, data from The Government of the United Kingdom revealed that in the financial year ending 2023, slightly over 1,862,500 individuals in England, or 3% of the population, received a GP diagnosis of coronary heart disease (CHD). Consequently, the increasing prevalence of chronic diseases is propelling the growth of the stem cell assay market.

The growing healthcare sector is projected to drive the expansion of the stem cell assay market. The healthcare sector, also referred to as the healthcare industry or healthcare system, encompasses a range of organizations, institutions, professionals, and resources committed to delivering medical services, healthcare products, and support aimed at maintaining or enhancing people's health. Within this sector, stem cell assays are utilized for drug discovery and development, toxicity testing, disease modeling, and exploring developmental biology. For example, in 2022, data from the Office for National Statistics, a UK-based national statistics organization focused on epilepsy, indicated that healthcare expenditure in the UK reached approximately $354.88 billion (£283 billion), reflecting a nominal increase of 0.7% compared to 2021 spending. Therefore, the growing healthcare sector is expected to propel the growth of the stem cell assay market in the future.

A key trend gaining traction in the stem cell assay market is product innovation. Major companies in this market are introducing new products to maintain their competitive positions. For example, in May 2022, Beckman Coulter Life Sciences, a US-based healthcare company, introduced the AQUOS STEM System designed to aid in the development of hematopoietic stem cells. This system reduces hands-on time by 95%, minimizes error-prone processes by 87.5%, and shortens turnaround times, running on the AQUIOS CL Flow Cytometer that combines sample preparation and analysis in a compact platform.

Innovative technologies such as the LIVE Cell Death Assay (LCDA) are being developed by major companies in the stem cell assay market to meet the growing demand. LCDA, an automated solution for profiling cell health, death, apoptosis, and necrosis, offers 13 viability and death-related metrics. For instance, in September 2022, Nanolive SA, a Switzerland-based biotechnology company, launched LCDA, which finds applications in drug discovery, enabling the analysis of cell conditions related to health, stress, cell death, and recovery. This method employs machine learning to automatically measure and track cell well-being and the progression of cell death while distinguishing between apoptosis and necrosis.

In July 2022, Fujifilm Cellular Dynamics Inc., a US-based manufacturer of human-induced pluripotent stem cell technologies, entered into a partnership with PhenoVista Biosciences. This collaboration aims to provide drug discovery researchers with services for high content screening imaging using iPSC-derived differentiated cells, contributing to the drug discovery process. PhenoVista Biosciences, a US-based company, specializes in offering imaging-based phenotypic assay services for drug discovery using induced pluripotent stem cells (iPSCs) in screening.

Major companies operating in the stem cell assay market include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Becton Dickinson and Company, Bio-Rad Laboratories Inc., PerkinElmer Inc., Agilent Technologies Inc., Promega Corporation, Cell Biolabs Inc., Miltenyi Biotec GmbH, STEMCELL Technologies Inc., Bio-Techne Corporation, Charles River Laboratories International Inc., Hemogenix Inc., Lonza Group AG, Takara Bio Inc., Creative Bioarray, AAT Bioquest Inc., BPS Bioscience Inc., Enzo Life Sciences Inc., PromoCell GmbH, Biotium Inc., Geno Technology Inc., Abcam plc, ReachBio Research Labs. Inc., Sartorius AG, Eppendorf AG, Corning Incorporated, MEDIPOST Co. Ltd., Anterogen Co. Ltd., Corestemchemon Inc., Pharmicell Inc., NuVasive Inc., RTI Surgical Holdings Inc., AlloSource LifeSource Services Inc., JCR Pharmaceuticals Co. Ltd.

North America was the largest region in the stem cell assay market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the global stem cell assay industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the stem cell assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The stem cell assay market consists of sales of tetrazolium reduction assays, resazurin cell viability assays, calcein-AM cell viability assays, proliferation assays, differentiation assays, function assays, caspase assays and annexin v and cell permeability assays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stem Cell Assay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stem cell assay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stem cell assay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stem cell assay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Cell Viability And Toxicity Assays; Cell Apoptosis Assays; Cell Function Assays; Cell Identification Assays; Isolation And Purification Assays; Cell Differentiation Assay; Other Types
  • 2) By Product: Instruments; Detection kit
  • 3) By Application: Regenerative Medicine And Therapy Development; Drug Discovery And Development; Clinical Research
  • 4) By End User: Government Research Institutes; Private Research Institutes; Industry Research
  • Subsegments:
  • 1) By Cell Viability and Toxicity Assays: MTT Assay; Resazurin Assay; ATP Assay; LDH Release Assay
  • 2) By Cell Apoptosis Assays: Caspase Activity Assays; Annexin V Staining Assays; TUNEL Assay; Cell Death Detection Assays
  • 3) By Cell Function Assays: Proliferation Assays; Migration and Invasion Assays; Differentiation Assays
  • 4) By Cell Identification Assays: Flow Cytometry-Based Assays; Surface Marker Characterization; Immunocytochemistry Assays
  • 5) By Isolation and Purification Assays: Magnetic-Activated Cell Sorting (MACS); Fluorescence-Activated Cell Sorting (FACS); Density Gradient Centrifugation
  • 6) By Cell Differentiation Assay: Lineage-Specific Differentiation Assays; Gene Expression Analysis During Differentiation
  • 7) By Other Types: 3D Culture Assays; High-Content Screening Assays; Biomarker Discovery Assays
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Danaher Corporation; Becton Dickinson and Company; Bio-Rad Laboratories Inc.; PerkinElmer Inc.; Agilent Technologies Inc.; Promega Corporation; Cell Biolabs Inc.; Miltenyi Biotec GmbH; STEMCELL Technologies Inc.; Bio-Techne Corporation; Charles River Laboratories International Inc.; Hemogenix Inc.; Lonza Group AG; Takara Bio Inc.; Creative Bioarray; AAT Bioquest Inc.; BPS Bioscience Inc.; Enzo Life Sciences Inc.; PromoCell GmbH; Biotium Inc.; Geno Technology Inc.; Abcam plc; ReachBio Research Labs. Inc.; Sartorius AG; Eppendorf AG; Corning Incorporated; MEDIPOST Co. Ltd.; Anterogen Co. Ltd.; Corestemchemon Inc.; Pharmicell Inc.; NuVasive Inc.; RTI Surgical Holdings Inc.; AlloSource LifeSource Services Inc.; JCR Pharmaceuticals Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Stem Cell Assay Market Characteristics

3. Stem Cell Assay Market Trends And Strategies

4. Stem Cell Assay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Stem Cell Assay Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Stem Cell Assay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Stem Cell Assay Market Growth Rate Analysis
  • 5.4. Global Stem Cell Assay Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Stem Cell Assay Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Stem Cell Assay Total Addressable Market (TAM)

6. Stem Cell Assay Market Segmentation

  • 6.1. Global Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Viability And Toxicity Assays
  • Cell Apoptosis Assays
  • Cell Function Assays
  • Cell Identification Assays
  • Isolation And Purification Assays
  • Cell Differentiation Assay
  • Other Types
  • 6.2. Global Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Detection Kit
  • 6.3. Global Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Regenerative Medicine And Therapy Development
  • Drug Discovery And Development
  • Clinical Research
  • 6.4. Global Stem Cell Assay Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Government Research Institutes
  • Private Research Institutes
  • Industry Research
  • 6.5. Global Stem Cell Assay Market, Sub-Segmentation Of Cell Viability and Toxicity Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • MTT Assay
  • Resazurin Assay
  • ATP Assay
  • LDH Release Assay
  • 6.6. Global Stem Cell Assay Market, Sub-Segmentation Of Cell Apoptosis Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Caspase Activity Assays
  • Annexin V Staining Assays
  • TUNEL Assay
  • Cell Death Detection Assays
  • 6.7. Global Stem Cell Assay Market, Sub-Segmentation Of Cell Function Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Proliferation Assays
  • Migration and Invasion Assays
  • Differentiation Assays
  • 6.8. Global Stem Cell Assay Market, Sub-Segmentation Of Cell Identification Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Flow Cytometry-Based Assays
  • Surface Marker Characterization
  • Immunocytochemistry Assays
  • 6.9. Global Stem Cell Assay Market, Sub-Segmentation Of Isolation and Purification Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Magnetic-Activated Cell Sorting (MACS)
  • Fluorescence-Activated Cell Sorting (FACS)
  • Density Gradient Centrifugation
  • 6.10. Global Stem Cell Assay Market, Sub-Segmentation Of Cell Differentiation Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lineage-Specific Differentiation Assays
  • Gene Expression Analysis During Differentiation
  • 6.11. Global Stem Cell Assay Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 3D Culture Assays
  • High-Content Screening Assays
  • Biomarker Discovery Assays

7. Stem Cell Assay Market Regional And Country Analysis

  • 7.1. Global Stem Cell Assay Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Stem Cell Assay Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Stem Cell Assay Market

  • 8.1. Asia-Pacific Stem Cell Assay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Stem Cell Assay Market

  • 9.1. China Stem Cell Assay Market Overview
  • 9.2. China Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Stem Cell Assay Market

  • 10.1. India Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Stem Cell Assay Market

  • 11.1. Japan Stem Cell Assay Market Overview
  • 11.2. Japan Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Stem Cell Assay Market

  • 12.1. Australia Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Stem Cell Assay Market

  • 13.1. Indonesia Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Stem Cell Assay Market

  • 14.1. South Korea Stem Cell Assay Market Overview
  • 14.2. South Korea Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Stem Cell Assay Market

  • 15.1. Western Europe Stem Cell Assay Market Overview
  • 15.2. Western Europe Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Stem Cell Assay Market

  • 16.1. UK Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Stem Cell Assay Market

  • 17.1. Germany Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Stem Cell Assay Market

  • 18.1. France Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Stem Cell Assay Market

  • 19.1. Italy Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Stem Cell Assay Market

  • 20.1. Spain Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Stem Cell Assay Market

  • 21.1. Eastern Europe Stem Cell Assay Market Overview
  • 21.2. Eastern Europe Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Stem Cell Assay Market

  • 22.1. Russia Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Stem Cell Assay Market

  • 23.1. North America Stem Cell Assay Market Overview
  • 23.2. North America Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Stem Cell Assay Market

  • 24.1. USA Stem Cell Assay Market Overview
  • 24.2. USA Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Stem Cell Assay Market

  • 25.1. Canada Stem Cell Assay Market Overview
  • 25.2. Canada Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Stem Cell Assay Market

  • 26.1. South America Stem Cell Assay Market Overview
  • 26.2. South America Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Stem Cell Assay Market

  • 27.1. Brazil Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Stem Cell Assay Market

  • 28.1. Middle East Stem Cell Assay Market Overview
  • 28.2. Middle East Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Stem Cell Assay Market

  • 29.1. Africa Stem Cell Assay Market Overview
  • 29.2. Africa Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Stem Cell Assay Market Competitive Landscape And Company Profiles

  • 30.1. Stem Cell Assay Market Competitive Landscape
  • 30.2. Stem Cell Assay Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Stem Cell Assay Market Other Major And Innovative Companies

  • 31.1. PerkinElmer Inc.
  • 31.2. Agilent Technologies Inc.
  • 31.3. Promega Corporation
  • 31.4. Cell Biolabs Inc.
  • 31.5. Miltenyi Biotec GmbH
  • 31.6. STEMCELL Technologies Inc.
  • 31.7. Bio-Techne Corporation
  • 31.8. Charles River Laboratories International Inc.
  • 31.9. Hemogenix Inc.
  • 31.10. Lonza Group AG
  • 31.11. Takara Bio Inc.
  • 31.12. Creative Bioarray
  • 31.13. AAT Bioquest Inc.
  • 31.14. BPS Bioscience Inc.
  • 31.15. Enzo Life Sciences Inc.

32. Global Stem Cell Assay Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Stem Cell Assay Market

34. Recent Developments In The Stem Cell Assay Market

35. Stem Cell Assay Market High Potential Countries, Segments and Strategies

  • 35.1 Stem Cell Assay Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Stem Cell Assay Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Stem Cell Assay Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer